See more : Distribution Finance Capital Holdings plc (DFCH.L) Income Statement Analysis – Financial Results
Complete financial analysis of Fisher & Paykel Healthcare Corporation Limited (FSPKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fisher & Paykel Healthcare Corporation Limited, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Idaho Strategic Resources, Inc. (IDR) Income Statement Analysis – Financial Results
- Givex Corp. (GIVXF) Income Statement Analysis – Financial Results
- Kaynes Technology India Limited (KAYNES.BO) Income Statement Analysis – Financial Results
- Onelife Capital Advisors Limited (ONELIFECAP.BO) Income Statement Analysis – Financial Results
- ISP Global Limited (8487.HK) Income Statement Analysis – Financial Results
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.76B | 1.59B | 1.64B | 1.95B | 1.27B | 1.12B | 1.02B | 947.16M | 908.34M | 651.32M | 612.48M | 631.90M | 592.18M | 633.62M | 617.00M | 594.63M | 402.12M | 395.05M | 337.76M | 262.22M | 247.64M | 229.15M | 259.51M | 232.59M |
| Cost of Revenue | 698.40M | 642.70M | 629.00M | 725.60M | 427.90M | 369.39M | 350.44M | 331.13M | 326.09M | 264.34M | 277.96M | 309.45M | 306.61M | 309.40M | 301.43M | 259.75M | 206.67M | 168.65M | 0.00 | 73.12M | 0.00 | 0.00 | 79.68M | 0.00 |
| Gross Profit | 1.06B | 945.90M | 1.01B | 1.22B | 845.50M | 747.43M | 672.56M | 616.03M | 582.24M | 386.99M | 334.52M | 322.45M | 285.57M | 324.22M | 315.57M | 334.88M | 195.45M | 226.40M | 337.76M | 189.10M | 247.64M | 229.15M | 179.84M | 232.59M |
| Gross Profit Ratio | 60.28% | 59.54% | 61.70% | 62.76% | 66.40% | 66.92% | 65.74% | 65.04% | 64.10% | 59.42% | 54.62% | 51.03% | 48.22% | 51.17% | 51.15% | 56.32% | 48.60% | 57.31% | 100.00% | 72.11% | 100.00% | 100.00% | 69.30% | 100.00% |
| Research & Development | 198.20M | 174.30M | 154.00M | 136.70M | 118.50M | 104.59M | 100.44M | 93.68M | 81.33M | 65.72M | 58.32M | 56.95M | 53.27M | 53.21M | 45.84M | 34.67M | 28.00M | 22.82M | 20.24M | 17.61M | 0.00 | 0.00 | 12.43M | 10.45M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.16M | 10.44M | 9.52M | 7.98M | 8.13M | 7.56M | 7.76M | 8.29M | 7.84M | 6.89M | 5.78M | 0.00 | 6.24M | 4.22M | 3.90M | 0.00 | 2.05M | 2.42M |
| Selling & Marketing | 492.80M | 431.90M | 393.10M | 396.60M | 338.00M | 341.47M | 308.54M | 293.36M | 268.87M | 182.96M | 184.69M | 189.09M | 180.99M | 192.22M | 178.75M | 145.66M | 113.74M | 110.39M | 0.00 | 73.27M | 0.00 | 0.00 | 0.00 | 56.20M |
| SG&A | 492.80M | 431.90M | 393.10M | 396.60M | 338.00M | 341.47M | 308.54M | 293.36M | 268.87M | 182.96M | 184.69M | 189.09M | 180.99M | 192.22M | 178.75M | 145.66M | 113.74M | 110.39M | 6.24M | 73.27M | 3.90M | 0.00 | 2.05M | 58.62M |
| Other Expenses | 0.00 | -7.60M | 40.20M | 32.40M | -16.80M | 3.44M | 22.70M | 34.13M | 2.22M | 33.71M | 64.02M | 65.73M | 70.96M | 53.64M | 42.67M | -29.15M | 13.86M | 8.17M | 40.72M | 13.07M | 12.32M | 0.00 | 15.09M | -60.26M |
| Operating Expenses | 691.00M | 705.20M | 643.10M | 618.30M | 517.50M | 489.50M | 456.29M | 429.59M | 389.27M | 280.70M | 275.21M | 278.94M | 262.87M | 275.34M | 247.27M | 201.52M | 159.76M | 148.21M | 257.08M | 100.51M | 166.23M | 157.21M | 88.77M | 76.30M |
| Cost & Expenses | 1.39B | 1.35B | 1.27B | 1.34B | 945.40M | 858.89M | 806.73M | 760.72M | 715.37M | 545.03M | 553.17M | 588.39M | 569.48M | 584.74M | 548.70M | 461.27M | 366.43M | 316.86M | 257.08M | 173.63M | 166.23M | 157.21M | 168.45M | 76.30M |
| Interest Income | 3.30M | 2.60M | 2.60M | 1.50M | 2.20M | 3.44M | 1.70M | 452.06K | 113.20K | 145.63K | 61.40K | 235.44K | 355.26K | 781.73K | 853.84K | 1.55M | 826.40K | 932.07K | 1.35M | 1.72M | 2.73M | 3.80M | 1.63M | 294.29K |
| Interest Expense | 18.20M | 6.70M | 4.90M | 5.00M | 3.90M | 4.90M | 3.92M | 3.84M | 11.49M | 11.59M | 8.38M | 6.11M | 5.50M | 7.46M | -4.31M | 22.80M | 5.27M | 3.26M | 937.89K | 367.56K | 516.35K | 501.36K | 1.95M | 2.65M |
| Depreciation & Amortization | 114.30M | 99.00M | 96.00M | 85.00M | 61.00M | 63.54M | 38.45M | 48.58M | 43.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.13M | 0.00 | 0.00 | 0.00 | 7.80M | 7.01M |
| EBITDA | 368.20M | 433.70M | 605.10M | 808.20M | 435.40M | 351.68M | 335.27M | 306.12M | 273.43M | 204.17M | 187.79M | 175.27M | 151.24M | 163.11M | 157.18M | 148.14M | 86.41M | 117.28M | 133.87M | 109.56M | 103.46M | 132.06M | 123.38M | 29.95M |
| EBITDA Ratio | 20.94% | 27.30% | 36.84% | 41.48% | 34.19% | 31.49% | 32.77% | 32.32% | 30.10% | 31.35% | 30.66% | 27.74% | 25.54% | 25.74% | 25.48% | 24.91% | 21.49% | 29.69% | 39.63% | 41.78% | 41.78% | 57.63% | 47.54% | 12.88% |
| Operating Income | 254.40M | 334.70M | 509.10M | 723.20M | 374.40M | 351.68M | 335.27M | 306.12M | 273.43M | 204.17M | 187.79M | 175.27M | 151.24M | 163.11M | 157.18M | 148.14M | 86.41M | 117.28M | 122.74M | 109.56M | 103.46M | 132.06M | 115.58M | 22.94M |
| Operating Income Ratio | 14.47% | 21.07% | 31.00% | 37.12% | 29.40% | 31.49% | 32.77% | 32.32% | 30.10% | 31.35% | 30.66% | 27.74% | 25.54% | 25.74% | 25.48% | 24.91% | 21.49% | 29.69% | 36.34% | 41.78% | 41.78% | 57.63% | 44.54% | 9.86% |
| Total Other Income/Expenses | -18.70M | 87.30M | 133.90M | 113.90M | 42.50M | 45.42M | 67.78M | 73.30M | 29.91M | 54.28M | 87.90M | 92.76M | 94.43M | 76.87M | 70.52M | -29.21M | 27.44M | 20.83M | 41.12M | 10.98M | -10.17M | -9.79M | -1.95M | -136.00M |
| Income Before Tax | 235.70M | 328.00M | 504.20M | 718.20M | 370.50M | 303.35M | 284.04M | 259.74M | 222.87M | 160.57M | 147.21M | 136.27M | 117.13M | 125.75M | 138.82M | 104.15M | 63.12M | 99.02M | 121.80M | 99.57M | 93.28M | 122.27M | 113.63M | 20.29M |
| Income Before Tax Ratio | 13.41% | 20.65% | 30.70% | 36.86% | 29.10% | 27.16% | 27.77% | 27.42% | 24.54% | 24.65% | 24.04% | 21.56% | 19.78% | 19.85% | 22.50% | 17.51% | 15.70% | 25.07% | 36.06% | 37.97% | 37.67% | 53.36% | 43.79% | 8.72% |
| Income Tax Expense | 103.10M | 77.70M | 127.30M | 194.00M | 83.20M | 85.42M | 82.31M | 75.48M | 63.71M | 46.11M | 42.67M | 40.28M | 35.79M | 54.66M | 45.73M | 27.93M | 22.12M | 33.86M | 40.19M | 99.57M | 93.28M | 122.27M | 38.18M | 20.29M |
| Net Income | 132.60M | 250.30M | 376.90M | 524.20M | 287.30M | 217.93M | 201.73M | 184.26M | 159.17M | 114.46M | 104.54M | 95.99M | 81.34M | 71.08M | 93.09M | 76.22M | 41.00M | 65.16M | 81.62M | 66.77M | 63.04M | 80.16M | 58.27M | 11.71M |
| Net Income Ratio | 7.54% | 15.76% | 22.95% | 26.91% | 22.56% | 19.51% | 19.72% | 19.45% | 17.52% | 17.57% | 17.07% | 15.19% | 13.74% | 11.22% | 15.09% | 12.82% | 10.20% | 16.49% | 24.16% | 25.46% | 25.46% | 34.98% | 22.45% | 5.03% |
| EPS | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.39 | 0.35 | 0.33 | 0.29 | 0.20 | 0.19 | 0.17 | 0.15 | 0.14 | 0.18 | 0.15 | 0.08 | 0.12 | 0.16 | 0.13 | 0.13 | 0.15 | 0.10 | 0.02 |
| EPS Diluted | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.38 | 0.35 | 0.33 | 0.28 | 0.20 | 0.18 | 0.17 | 0.15 | 0.13 | 0.18 | 0.15 | 0.08 | 0.12 | 0.15 | 0.13 | 0.12 | 0.15 | 0.10 | 0.02 |
| Weighted Avg Shares Out | 586.73M | 578.14M | 576.95M | 574.19M | 574.19M | 572.78M | 570.02M | 566.13M | 561.04M | 555.54M | 547.10M | 537.56M | 525.71M | 517.15M | 511.25M | 509.49M | 509.40M | 510.85M | 508.38M | 508.69M | 512.12M | 511.84M | 559.63M | 511.36M |
| Weighted Avg Shares Out (Dil) | 586.18M | 581.63M | 579.99M | 579.05M | 579.05M | 578.05M | 576.36M | 573.40M | 571.41M | 568.71M | 557.78M | 558.36M | 547.95M | 535.37M | 530.60M | 527.40M | 526.51M | 523.68M | 526.05M | 524.83M | 525.95M | 520.74M | 559.63M | 511.36M |
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2025 Earnings Call Transcript
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2024 Earnings Call Transcript
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports